Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    18550886 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy
Condition: Infantile Hemangioma
Interventions: Drug: Propranolol;   Drug: Placebo
2 Terminated Propranolol in Capillary Hemangiomas
Condition: Hemangioma, Capillary
Interventions: Drug: propranolol treatment;   Drug: placebo treatment
3 Terminated
Has Results
Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas
Condition: Hemangioma of Infancy
Interventions: Drug: propranolol;   Drug: Prednisolone
4 Recruiting Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: propranolol
5 Not yet recruiting MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients
Condition: Melanoma
Interventions: Drug: Propranolol;   Drug: Placebo
6 Recruiting Sildenafil for the Treatment of Lymphatic Malformations
Conditions: Lymphatic Malformations;   Lymphatic Diseases
Interventions: Drug: Sildenafil 20 mg tablets;   Other: Placebo tablets (resembling Revatio)
7 Recruiting Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
Conditions: Sturge Weber Syndrome;   Port-wine Mark
Interventions: Drug: Timolol;   Drug: Preservative free artificial tear gel.
8 Completed Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
Condition: Hemangioma
Interventions: Drug: Propranolol;   Drug: Prednisone

Study has passed its completion date and status has not been verified in more than two years.